Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: Re: JD on Stockhouse - Her2-positive brain metastases

JD... "From a proof of concept standpoint it would serve no purpose because xB3 is not a therapeutic. xB3 really only makes sense as an attachment to a therapeutic payload, a drug."

So there will be many Phase 1 Trials with each new Therapeutic payload piggybacking xB3?

 

Koo

Share
New Message
Please login to post a reply